Literature DB >> 12409557

Fulminant hepatitis E in Japan.

Kazuyuki Suzuki, Tatsuya Aikawa, Hiroaki Okamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12409557     DOI： 10.1056/NEJM200210313471819

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient.

Authors:  Toshinori Tanaka; Masaharu Takahashi; Hideyuki Takahashi; Koji Ichiyama; Yu Hoshino; Shigeo Nagashima; Hitoshi Mizuo; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

2.  Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection.

Authors:  Masaharu Takahashi; Shigeyuki Kusakai; Hitoshi Mizuo; Kazuyuki Suzuki; Kuniko Fujimura; Kazuo Masuko; Yoshiki Sugai; Tatsuya Aikawa; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Autochthonous sporadic acute hepatitis E caused by two distinct subgenotype 3b hepatitis E virus strains with only 90% nucleotide identity.

Authors:  Yasuko Yamaguchi; Hitoshi Takagi; Yuhei Suzuki; Kyoko Maruhashi; Takashi Kosone; Satoru Kakizaki; Ken Sato; Masanobu Yamada; Shigeo Nagashima; Masaharu Takahashi; Hiroaki Okamoto
Journal:  Clin J Gastroenterol       Date:  2017-02-15

4.  A case of fulminant hepatic failure caused by hepatitis E virus.

Authors:  Masataka Tsuge; Chiemi Noguchi; Nobuhiko Hiraga; Nami Mori; Akira Hiramatsu; Michio Imamura; Waka Ohishi; Keiko Arataki; Hiroshi Aikata; Yoshiiku Kawakami; Shoichi Takahashi; Kazuaki Chayama
Journal:  Clin J Gastroenterol       Date:  2008-06-03

5.  Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan.

Authors:  Jun Inoue; Yoshiyuki Ueno; Futoshi Nagasaki; Takehiro Akahane; Koji Fukushima; Takayuki Kogure; Yasuteru Kondo; Eiji Kakazu; Keiichi Tamai; Osamu Kido; Yu Nakagome; Masashi Ninomiya; Noriyuki Obara; Yuta Wakui; Masaharu Takahashi; Hiroaki Okamoto; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

Review 6.  An update on the hepatitis E virus.

Authors:  Seth N Sclair; Eugene R Schiff
Journal:  Curr Gastroenterol Rep       Date:  2013-02

7.  Hepatitis E, Helicobacter pylori, and gastrointestinal symptoms in workers exposed to waste water.

Authors:  S Jeggli; D Steiner; H Joller; A Tschopp; R Steffen; P Hotz
Journal:  Occup Environ Med       Date:  2004-07       Impact factor: 4.402

8.  Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system.

Authors:  Masaharu Takahashi; Toshinori Tanaka; Masahiro Azuma; Eiji Kusano; Tatsuya Aikawa; Takao Shibayama; Yasuyuki Yazaki; Hitoshi Mizuo; Jun Inoue; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

9.  Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation.

Authors:  Masaharu Takahashi; Toshinori Tanaka; Hideyuki Takahashi; Yu Hoshino; Shigeo Nagashima; Hitoshi Mizuo; Yasuyuki Yazaki; Tomofumi Takagi; Masahiro Azuma; Eiji Kusano; Norio Isoda; Kentaro Sugano; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

10.  Evaluation of hepatitis E antigen kinetics and its diagnostic utility for prediction of the outcomes of hepatitis E virus genotype 1 infection.

Authors:  Mohamed A El-Mokhtar; Haidi Karam-Allah Ramadan; Muhamad R Abdel Hameed; Ayat M Kamel; Sahar A Mandour; Maha Ali; Mohamed A Y Abdel-Malek; Doaa M Abd El-Kareem; Sara Adel; Eman H Salama; Khaled Abo Bakr Khalaf; Ibrahim M Sayed
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.